- Article
Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
- Delaney Wolfe,
- Qiuhong Zhao,
- Emma Siegel,
- Marcin Puto,
- Danielle Murphy,
- Julianna Roddy,
- Yvonne Efebera and
- Justin Tossey
Cytomegalovirus (CMV) is the most clinically significant infection after allogeneic hematopoietic-cell transplantation (allo-HCT) and is associated with increased mortality. The risk for CMV reactivation increases with graft versus host disease (GVHD...

